小児の機能性発作: 人口統計,臨床,心理学的特徴,リスク要因
Sherifa Ahmed Hamed1, Ali Farrag ElHadad2, Mohamed Fawzy1
1Department of Neurology and Psychiatry, Assiut University Hospital, Assiut, Egypt.
Epilepsy & behavior : E&B
|February 17, 2026
まとめ
精神性非発作 (PNES) とも呼ばれる小児機能性発作 (FS) は,の診療所で一般的であり,患者の約15%に影響します. FSの早期診断と管理は,長期的な発達問題を予防するために不可欠です.
科学分野:
- 神経学 神経学とは
- 小児科は小児科です.
- 精神科医は精神病を患っている.
背景:
- 小児の機能性発作 (FS),または精神性非性発作 (PNES) は,成人の集団と比較して十分に研究されていない.
- 小児FSの罹患率,臨床的特徴,および予測要因を理解することは,患者のアウトカムを改善するために不可欠です.
研究 の 目的:
- 小児のエピレプシークリニックにおけるFSの罹患率を決定する.
- 小児FSに関連する臨床パターン,行動特性,リスク予測要因を調査する.
主な方法:
- 患者は,外科医の小児性の診療所から募集されました.
- データには,人口統計,臨床的特徴,ビデオ電気脳図,精神科医のインタビュー,および心理測定アンケート (児童行動チェックリスト) が含まれていました.
主要な成果:
- 小児のエピレプシー診療所でFSの罹患率は15.42%で,ミックスエピレプシーとFSの罹患率は5.14%でした.
- FSは主に青少年 (66.7%) に影響し,平均年齢は14歳であり,診断の遅れは4〜14ヶ月であった.
- FSの患者は,子供の行動チェックリスト (不安,体性化,注意欠陥) で高いスコアを示し,コントロールとエピレプシー患者と比較して,内部化/外部化行動の問題を示した.
結論:
- 機能性発作は,小児のてんかんクリニックで頻繁に診断され,しばしばてんかんとして誤診されます.
- 自己効力性の衝突や学校/家族の問題などの心理社会的要因は,FSの重要な予測要因です.
- 小児FSの早期診断と管理は,人格,社会的相互作用,学業成績への負の影響を軽減するために非常に重要です.
関連する概念動画
01:13Seizures: Classification
1.7K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.7K
01:24Epilepsy and Seizures: Overview
1.4K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.4K
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
258
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
258
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
334
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
334
01:30Attention-Deficit/Hyperactivity Disorder
1.1K
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.1K
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
338
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
338